Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and Anticancer Evaluation of New 1,3,4-Oxadiazole Derivatives
Camelia Elena Stecoza, George Mihai Niţulescu, Constantin Drǎghici, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 438-438
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors
Tarek A. Yousef, Abdulrahman G. Alhamzani, Mortaga M. Abou–Krisha, et al.
Heliyon (2023) Vol. 9, Iss. 2, pp. e13460-e13460
Open Access | Times Cited: 20
Coumarin derivatives containing the 1,3,4 oxadiazole/thiadiazole moiety discovered as potential anti-tobacco mosaic virus agents
Yuzhi Hu, Zhiling Sun, Wei Zeng, et al.
Molecular Diversity (2025)
Open Access
Exploration of novel isoniazid embedded 1,3,4-oxadiazole hybrids as anti-TB, antioxidant, and COX inhibitors: synthesis, spectral analysis, and molecular modeling studies
S. Jisha, Nagesh Gunavanthrao Yernale, Prashantha Karunakar, et al.
Journal of the Iranian Chemical Society (2025)
Closed Access
New Pyrrole Derivatives as Promising Biological Agents: Design, Synthesis, Characterization, In Silico, and Cytotoxicity Evaluation
Beatrice-Cristina Ivan, Ștefania‐Felicia Bărbuceanu, Camelia Mia Hotnog, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8854-8854
Open Access | Times Cited: 31
An Understanding of Mechanism-Based Approaches for 1,3,4-Oxadiazole Scaffolds as Cytotoxic Agents and Enzyme Inhibitors
Davinder Kumar, Navidha Aggarwal, Aakash Deep, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 254-254
Open Access | Times Cited: 19
Semisynthesis and biological evaluation of novel honokiol thioethers against colon cancer cells HCT116 via inhibiting the transcription and expression of YAP protein
Ruige Yang, Xiang-Jing Fu, Jiangping Fan, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 107, pp. 117762-117762
Closed Access | Times Cited: 4
Mechanism-based approaches of 1,3,4 thiadiazole scaffolds as potent enzyme inhibitors for cytotoxicity and antiviral activity
Davinder Kumar, Harsh Kumar, Virender Kumar, et al.
Medicine in Drug Discovery (2022) Vol. 17, pp. 100150-100150
Open Access | Times Cited: 24
Discovery of PIM-1 kinase inhibitors based on the 2,5-disubstituted 1,3,4-oxadiazole scaffold against prostate cancer: Design, synthesis, in vitro and in vivo cytotoxicity investigation
Anne‐Sophie Castanet, Mohamed S. Nafie, Sara A. Said, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115220-115220
Closed Access | Times Cited: 12
Synthesis and Biological Activity of Some New 1,3,4-Oxadiazoles Derived from Carboxylic Acids
I. A. A. Hamdan, Jumbad H. Tomma
Russian Journal of Organic Chemistry (2024) Vol. 60, Iss. 1, pp. 164-172
Closed Access | Times Cited: 3
Synthesis, structural, biocomputational modeling and antifungal activity of novel armed pyrazoles
Abderrahim Titi, Rachid Touzani, Anna Moliterni, et al.
Journal of Molecular Structure (2022) Vol. 1264, pp. 133156-133156
Closed Access | Times Cited: 18
Synthesis of Some New 1,3,4-Oxadiazole Derivatives and Evaluation of Their Anticancer Activity
Leyla Yurttaş, Asaf Evrim Evren, Aslıhan Kubilay, et al.
ACS Omega (2023) Vol. 8, Iss. 51, pp. 49311-49326
Open Access | Times Cited: 10
Synthesis, Anticancer, Antimicrobial and Antioxidant Potential of Novel 4-(Substituted phenyl-1,3,4-oxadiazol/thiadiazol-2-yl)-4-(4-substituted phenyl) Azetidin-2-One Derivatives
Davinder Kumar, Navidha Aggarwal, Virender Kumar, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 517-517
Open Access | Times Cited: 8
Synthesis of 1,3,4-Thiadiazole Derivatives and Their Anticancer Evaluation
Camelia Elena Stecoza, George Mihai Niţulescu, Constantin Drǎghici, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17476-17476
Open Access | Times Cited: 8
Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
Marinela Bostan, Mirela Mihăilă, Georgiana Gabriela Petrică-Matei, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6322-6322
Open Access | Times Cited: 21
Potential Synthetic Routes and Metal-Ion Sensing Applications of 1,3,4-Oxadiazoles: An Integrative Review
Deepak Sharma, Hari Om, Ashok K. Sharma
Critical Reviews in Analytical Chemistry (2022) Vol. 54, Iss. 2, pp. 416-436
Closed Access | Times Cited: 14
Pyridine-Based Glycosides Bearing 1,2,4-Triazole and Their 1,3,4-oxadiazole analogues as Potential EGFR and CDK-2 Inhibitors: Design, Synthesis, Antiproliferative Activity and In Silico Studies
Asmaa F. Kassem, Ahmed Younis, Eman S. Nossier, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138741-138741
Closed Access | Times Cited: 1
Cholyl 1,3,4-oxadiazole hybrid compounds: design, synthesis and antimicrobial assessment
Anas J. Rasras, Mohamed El‐Naggar, Nesreen A. Safwat, et al.
Beilstein Journal of Organic Chemistry (2022) Vol. 18, pp. 631-638
Open Access | Times Cited: 10
Antioxidant properties of butylated phenol with oxadiazole and hydrazone moiety atorthoposition supported by DFT study
Raied Mustafa Shakir, Muhammad Kumayl Abd Wahab, Nurdiana Nordin, et al.
RSC Advances (2022) Vol. 12, Iss. 27, pp. 17085-17095
Open Access | Times Cited: 9
Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives
Az‐Eddine El Mansouri, Saida Lachhab, Ali Oubella, et al.
Journal of Molecular Structure (2022) Vol. 1272, pp. 134135-134135
Open Access | Times Cited: 9
Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies
Bushra Bashir, Naheed Riaz, Syeda Abida Ejaz, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106144-106144
Closed Access | Times Cited: 9
New Heterocyclic Compounds from Oxazol-5(4H)-one and 1,2,4-Triazin-6(5H)-one Classes: Synthesis, Characterization and Toxicity Evaluation
Ștefania‐Felicia Bărbuceanu, Elena-Valentina Rosca, Theodora-Venera Apostol, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4834-4834
Open Access | Times Cited: 5
Synthesis, Biological Activity and DFT Studies of 1,3,4-oxadiazole Ring in Combination with Pyridinium Salt
Mohammad H. Rababa, Majd M. Alsaleh, Alaa A. Abusamhadaneh, et al.
Current Organic Chemistry (2023) Vol. 27, Iss. 1, pp. 62-70
Closed Access | Times Cited: 4
Novel Bovine Serum Albumin-Decorated–Nanostructured Lipid Carriers Able to Modulate Apoptosis and Cell-Cycle Response in Ovarian, Breast, and Colon Tumoral Cells
Robert Țincu, Mirela Mihăilă, Marinela Bostan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1125-1125
Open Access | Times Cited: 4
1,3,4-Oxadiazole: An Emerging Scaffold to Inhibit the Thymidine Phosphorylase as an Anticancer Agent
Anjali Murmu, Purusottam Banjare, Balaji Wamanrao Matore, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 38, pp. 6227-6250
Closed Access | Times Cited: 3
Coumarin (Lipophobic), Thia/Oxa Diazole (Linker), Amino (Anchoring) Conjugated Scaffolds: Synthesis, In Silico, and In Vitro Cell Viability Studies
Rajeswari Kannuri, Shireesha Manturthi, Amar nath Velidandi
Russian Journal of Bioorganic Chemistry (2023) Vol. 49, Iss. 5, pp. 993-999
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top